MULTIVARIATE ANALYSIS TO IDENTIFY POTENTIAL BIOMARKERS FOR PROGNOSIS AND TREATMENT RESISTANCE IN HEAD AND NECK CANCER PATIENTS
It is estimated that nearly 50,000 individuals in the United States will be diagnosed with head and neck cancer in 2017 (American Cancer Society www.cancer.org). Ninety percent of oral cancers are head and neck squamous cell carcinoma (HNSCC). Major obstacles in the treatment of HNSCC are recurrence...
Main Author: | Wicker, Christina Ann |
---|---|
Format: | Others |
Published: |
UKnowledge
2018
|
Subjects: | |
Online Access: | https://uknowledge.uky.edu/toxicology_etds/19 https://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1018&context=toxicology_etds |
Similar Items
-
Diagnosis and Radioimmunotherapy of Head and Neck Squamous Cell Carcinomas
by: Ekberg, Tomas
Published: (2008) -
Antibody-Based Radionuclide Targeting for Diagnostics and Therapy : Preclinical Studies on Head and Neck Cancer
by: Nestor, Marika
Published: (2006) -
Cyclooxygenase-2 Expression in Squamous Cell Carcinoma of the Head and Neck
by: Mozhgan Mokhtari, et al.
Published: (2017-10-01) -
Radioimmunotherapy in Experimental Head and Neck Squamous Cell Carcinoma : Tumour-targeting in vitro and in vivo
by: Cheng, Junping
Published: (2005) -
Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma
by: Hui Li, et al.
Published: (2021-03-01)